Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Biomea Fusion, Inc.NASDAQ: BMEA
Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares growth accelerates
Q1 FY2026 weighted avg shares of 72.3M shares rose 97.4% year over year, ahead of the +55.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +21.3% a year.
Context
- Weighted avg shares increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +97.4% holds above the trailing-twelve-month pace of +55.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 52.23M USD
- Year-over-year change
- +44.7%
- 4-year CAGR
- +21.6%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.23M | +44.7% |
| FY2024 | 2024-12-31 | 36.11M | +5.9% |
| FY2023 | 2023-12-31 | 34.11M | +16.5% |
| FY2022 | 2022-12-31 | 29.27M | +22.7% |
| FY2021 | 2021-12-31 | 23.86M | — |
Weighted Avg Shares vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's LTM Mar 2026 weighted avg shares of 56.46M shares is the 4th highest of the 9 companies compared; the peer median is 53.4M shares.
- Its year-over-year change of +55.6% is the 5th highest of 9, against a peer median of +67.9%.
- Over three fiscal years its annual growth of +21.3% compares with a peer median of +16.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
CBUSCibus, Inc. | LTM Mar 2026 | 301.04M | +1164.8% | -7.5% |
| LTM Mar 2026 | 107.08M | +1278.7% | +372.5% | |
| LTM Mar 2026 | 66.33M | +37.1% | +16.8% | |
| LTM Mar 2026 | 56.46M | +55.6% | +21.3% | |
| LTM Mar 2026 | 53.9M | +2.3% | +9.7% | |
| LTM Mar 2026 | 52.9M | +2.4% | +4.8% | |
| LTM Mar 2026 | 37.54M | +102.0% | — | |
| LTM Mar 2026 | 19.58M | +98.7% | +69.8% | |
| LTM Mar 2026 | 6.42M | -22.0% | +18.8% | |
| Peer median (excluding BMEA) | 53.4M | +67.9% | +16.8% | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| Weighted Avg Shares | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
| Weighted Avg Shares (Diluted) | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.